Rétatrute 5mg

Details

Retatrutide is a next-generation metabolic peptide classified as a triple agonist because it activates three key hormone receptors: GLP-1, GIP, and GCGR. By engaging a broader receptor profile than single or dual-agonist compounds, Retatrutide is widely studied in models involving appetite signaling, glucose regulation, energy expenditure, and body composition. Its expanded receptor activity makes it especially relevant for comparative metabolic research where researchers are evaluating the differences between GLP-1, dual-agonist, and triple-agonist pathways. Taken together, these characteristics position the material for structured studies where pathway-specific activity, comparative response, and consistency across experimental conditions matter.

Reconstitution

Add 1 mL of bacteriostatic water to the vial. This creates a solution that is 5 mg/mL. On a U-100 syringe, 10 units equals 0.1 mL, which contains 0.5 mg of active material.

Storage

Store lyophilized vials in a cool, dry, dark location until ready for laboratory use. Keep vials sealed and protected from moisture, direct light, and unnecessary temperature fluctuation. After reconstitution, store refrigerated unless your validated protocol specifies otherwise. Minimize repeated warming and cooling, avoid repeated freeze-thaw cycles, and label prepared vials with the preparation date and concentration.

Shipping

Orders are packed carefully before shipment. Fulfillment can take up to 5 business days depending on the product, order size, and current processing volume. After fulfillment, express shipping usually takes about 2 business days, though final carrier timing can vary by destination and service conditions. Tracking details are emailed once the order has been packed and fulfilled.